Current investigations have revealed that the percentage of CD4+CXCR5+Tfh to CD4+T cells in the PB of patients with myasthenia gravis is considerably greater than that of healthy controls and there is a positive correlation between the percentage and the stage of the disease [32, 33]. This evidence concerns the gene CXCR5 and myasthenia gravis.